1887

Abstract

SUMMARY

Quantitative aspects of Epstein—Barr virus infection and transformation of human neonatal B-lymphocytes have been investigated. 72 to 90% B-cells were obtained with enrichment. Of the B-cells, 19 to 97% showed nuclear antigen (EBNA) 2 days after infection. A difference between different B-cell donors in susceptibility to infection was noted. Analysis of the virus dose—response curves obtained with twofold virus dilutions showed that one virus particle is sufficient to induce EBNA in a cell. Of the infected cells, 50 to 95% multiplied in microtitre wells containing a human fibroblast feeder layer, while only a small proportion established growing colonies in soft agarose, that could be picked up and subcultured.

Keyword(s): EBNA , EBV and lymphocytes
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-3-539
1983-03-01
2022-01-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/3/JV0640030539.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-3-539&mimeType=html&fmt=ahah

References

  1. Aya T., Osato T. 1974; Early events in transformation of human cord leukocytes by Epstein–Barr virus: induction of DNA synthesis, mitosis and virus associated nuclear antigen synthesis. International Journal of Cancer 14:341–347
    [Google Scholar]
  2. Bianco C., Patric R., Nussenzweig V. 1970; A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Journal of Experimental Medicine 132:702–720
    [Google Scholar]
  3. Böyum A. 1968; Separation of leukocytes from blood and bone marrow. Scandinavian Journal of Clinical Laboratory Investigation 21: suppl 9777–89
    [Google Scholar]
  4. Chano R. S., Golden H. D. 1971; Transformation of human leukocytes by throat washings from infectious mononucleosis patients. Nature, London 234:359–360
    [Google Scholar]
  5. Chang R. S., Fillingame R. A., Paglieroni T., Glassy F. J. 1976; A procedure for quantifying the susceptibility of human lymphocytes to transformation by Epstein–Barr viruses. Proceedings of the Society for Experimental Biology and Medicine 153:193–196
    [Google Scholar]
  6. Cornain S., Carnod C., Silverman D., Klein E., Rajewsky M. 1975; Spleen-cell reactivity against transplanted neurogenic rat tumors induced by ethyl-nitrosourea: uncovering of tumor specificity after removal of complement receptor-bearing lymphocytes. International Journal of Cancer 16:301–311
    [Google Scholar]
  7. Davis D. B., Dulbecco R., Ginsberg H. S., Eisen H. N., Barry Wood W. Jr 1968 Principles of Microbiology and Immunology pp 660–671 New York, Evanston & London: Harper & Row;
    [Google Scholar]
  8. Einhorn L., Ernberg I. 1978; Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. International Journal of Cancer 21:157–160
    [Google Scholar]
  9. Einhorn L., Steinitz M., Yefenof E., Ernberg I., Bakacs T., Klein G. 1978; Epstein–Barr virus (EBV) receptors, complement receptors and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein–Barr virus studies. Cellular Immunology 35:43–58
    [Google Scholar]
  10. Gerber P., Whang-Peng J., Monroe J. H. 1969; Transformation and chromosome changes induced by Epstein–Barr virus in normal human leukocyte cultures. Proceedings of the National Academy of Sciences, U. S. A 63:740–747
    [Google Scholar]
  11. Henderson E., Miller G., Robinson J., Heston L. 1977; Efficiency of transformation of lymphocytes by Epstein–Barr virus. Virology 76:152–163
    [Google Scholar]
  12. Henle W., Diehl V., Kohn G., Zur Hausen H., Henle G. 1967; Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157:1064–1065
    [Google Scholar]
  13. Jondal M. 1974; Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes. Scandinavian Journal of Immunology 3:739–747
    [Google Scholar]
  14. Jondal M., Klein G. 1973; Surface markers on human B and T lymphocytes. II. Presence of Epstein–Barr virus receptors on B lymphocytes. Journal of Experimental Medicine 138:1365–1378
    [Google Scholar]
  15. Katsuki T., Hinuma Y. 1976; A quantitative analysis of the susceptibility of human leukocytes to transformation by Epstein–Barr virus. International Journal of Cancer 18:7–13
    [Google Scholar]
  16. Katsuki T., Hinuma Y., Yamamoto N., Abo T., Kumagai K. 1977; Identification of the target cells in human B lymphocytes for transformation by Epstein–Barr virus. Virology 83:287–294
    [Google Scholar]
  17. Menezes J., Jondal M., Leibold W., Dorval G. 1976; Epstein–Barr virus interaction with human lymphocyte subpopulation: virus adsorption, kinetics of expression of EBV-associated nuclear antigen (EBNA) and lymphocyte transformation. Infection and Immunity 13:303–310
    [Google Scholar]
  18. Miller G., Lipman M. 1973; Release of infectious Epstein–Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences, U. S. A 70:190–194
    [Google Scholar]
  19. Miller G., Lisco H., Kohn H. T., Stitt D. 1971; Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein–Barr virus and neutralization by human sera with Epstein–Barr virus antibody. Proceedings of the Society for Experimental Biology and Medicine 137:1459–1465
    [Google Scholar]
  20. Mizuno F., Aya T., Osato T. 1976; Growth in semisolid agar medium of human cord leukocytes freshly transformed by Epstein–Barr virus. Journal of the National Cancer Institute 56:171–173
    [Google Scholar]
  21. Moss D. J., Rickinson A. B., Wallace L. E., Epstein M. A. 1981; Sequential appearance of Epstein–Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature, London 291:664–666
    [Google Scholar]
  22. Nilsson K., Giovanella B., Stehlin J. S., Klein G. 1977; Tumorigenicity of human hematopoetic cell lines in athymic nude mice. International Journal of Cancer 19:337–344
    [Google Scholar]
  23. Pope J. H., Horne M. K., Scott W. 1968; Transformation of foetal human leukocytes in vitro by filtrates of a human leukemic cell line containing herpes-like virus. International Journal of Cancer 3:857–866
    [Google Scholar]
  24. Reedman B., Klein G. 1973; Cellular localization of an EBV-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
  25. Robinson J., Miller G. 1975; Assay for Epstein–Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood. Journal of Virology 15:1065–1072
    [Google Scholar]
  26. Schneider U., Zur Hausen H. 1975; Epstein–Barr virus induced transformation of human leukocytes after cell fractionation. International Journal of Cancer 15:59–65
    [Google Scholar]
  27. Steele C. M., Philipsson J., Arthur E., Gardiner S. E., Newton M. M., Mcintoh R. V. 1977; Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature, London 270:729–730
    [Google Scholar]
  28. Sugden B., Mark W. 1977; Clonal transformation of adult human leukocytes by Epstein–Barr virus. Journal of Virology 23:503–508
    [Google Scholar]
  29. Tsukuda K., Volsky D. J., Shapiro I. M., Klein G. 1982; Epstein–Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infection. European Journal of Immunology 12:87–90
    [Google Scholar]
  30. Yamamoto N., Hinuma Y. 1976; Clonal transformation of human leukocytes by Epstein–Barr virus in soft agar. International Journal of Cancer 17:191–196
    [Google Scholar]
  31. Yefenof E., Klein G., Jondal M., Oldstone M. B. A. 1976; Surface markers on human B and T lymphocytes. IX. Two color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines. International Journal of Cancer 17:693–700
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-64-3-539
Loading
/content/journal/jgv/10.1099/0022-1317-64-3-539
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error